This document is an excerpt from the EUR-Lex website
Document 62016CN0329
Case C-329/16: Request for a preliminary ruling from the Conseil d’État (Council of State) (France) lodged on 13 June 2016 — Syndicat national de l’industrie des technologies médicales (SNITEM) and Philips France v Premier ministre and Ministre des Affaires sociales et de la Santé
Case C-329/16: Request for a preliminary ruling from the Conseil d’État (Council of State) (France) lodged on 13 June 2016 — Syndicat national de l’industrie des technologies médicales (SNITEM) and Philips France v Premier ministre and Ministre des Affaires sociales et de la Santé
Case C-329/16: Request for a preliminary ruling from the Conseil d’État (Council of State) (France) lodged on 13 June 2016 — Syndicat national de l’industrie des technologies médicales (SNITEM) and Philips France v Premier ministre and Ministre des Affaires sociales et de la Santé
OJ C 296, 16.8.2016, p. 22–23
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
16.8.2016 |
EN |
Official Journal of the European Union |
C 296/22 |
Request for a preliminary ruling from the Conseil d’État (Council of State) (France) lodged on 13 June 2016 — Syndicat national de l’industrie des technologies médicales (SNITEM) and Philips France v Premier ministre and Ministre des Affaires sociales et de la Santé
(Case C-329/16)
(2016/C 296/30)
Language of the case: French
Referring court
Conseil d’État
Parties to the main proceedings
Applicants: Syndicat national de l’industrie des technologies médicales (SNITEM) and Philips France
Defendants: Premier ministre and Ministre des Affaires sociales et de la Santé
Question referred
Must [Council] Directive 93/42/EEC of 14 June 1993 [concerning medical devices (OJ 1993 L 169, p. 1)] be interpreted as meaning that software, the purpose of which is to offer to prescribers practising in towns, a health establishment or a medico-social establishment support for determining a drug prescription, in order to improve the safety of prescription, facilitate the work of the prescriber, encourage conformity of the prescription with national regulatory requirements and reduce the cost of treatment at the same quality, constitutes a medical device within the meaning of that directive, where that software has at least one function that permits the use of data specific to a patient to help his doctor issue his prescription, in particular by detecting contraindications, drug interactions and excessive doses, even though it does not itself act in or on the human body?